During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
Hollywood actor Mickey Rourke made a return to the boxing ring today aged 62, defeating an opponent less than half his age.
Poland has warned the UK that it will block any plans to discriminate between British and EU citizens.
The world's biggest ritual animal slaughter has begun in Nepal, amid protests. Readers may find images in this article distressing.